Screening for breast cancer

Stephen W. Duffy, Robert A. Smith, Rhian Gabe, László Tabár, Amy M F Yen, Tony H H Chen

研究成果: 雜誌貢獻文章同行評審

19 引文 斯高帕斯(Scopus)


Strong evidence supports the value of breast cancer screening with mammography, and high-quality mammography screening can be considered a major public health achievement [99]. As noted earlier in the discussion about the evaluation of service screening, the group of women who did not participate in mammographic screening in the decades after screening had been introduced had essentially unchanged or only minor improvements in mortality compared with the pattern before the introduction of screening, despite widespread use of adjuvant chemotherapy or hormonal therapy [100]. Breast cancer should be treated in its preclinical phase if we are to save the lives of women with this disease, and a considerable body of evidence outlines best practices that, with broader adherence, would result in greater breast cancer mortality reductions than have been observed to date.
頁(從 - 到)671-697
期刊Surgical Oncology Clinics of North America
出版狀態已發佈 - 10月 2005

ASJC Scopus subject areas

  • 腫瘤科
  • 手術


深入研究「Screening for breast cancer」主題。共同形成了獨特的指紋。